The Enteral Feeding Devices Market is likely to expand its roots at an average CAGR of 4.0% during the forecast period. The market is anticipated to hold a share of USD 2.8 billion in 2023 while it is anticipated to cross a value of USD 4.1 billion by 2033.
The research report on the enteral feeding devices market explains that the expanding healthcare services along with increasing intensive care units and proficient dialysis systems are gaining traction in the market.
The proliferation of private healthcare systems along with the advent of home-based enteral feeding devices are likely to expand the enteral feeding devices market size. Patients with organ failure that go through dialysis procedures require regular nutrient-feeding demand for enteral feeding devices.
Enteral feeding pumps are used as an alternative to gravity and syringe methods of feeding to deliver enteral nutrition. Pumps can be used to administer bolus and intermittent feeds, as well as for continuous feeding.
An increase in accidents is another reason why victims end up in temporary and permanent conditions where enteral feeding devices are the only option through which nutritional supplements can be fed.
The enteral feeding devices market outlook states that emerging economies such as India and China are building and restructuring their healthcare systems. In the process, the authorities are adopting the latest equipment and technology to counter any serious health crisis.
Thus, higher adoption of enteral feeding devices is expected during the forecast period. Advanced feeding pumps and enteral feeding tubes make up the applications of NICUs and ICUs.
Furthermore, the small healthcare spaces that cover a locality have also started offering feeding support to critical patients. Therefore, as the demand for critical care equipment rises, the enteral feeding devices market is likely to expand its boundaries in the potential marketplaces.
Attributes | Details |
---|---|
Enteral Feeding Devices Market CAGR (2023 to 2033) | 4.0% |
Enteral Feeding Devices Market Size (2023) | USD 2.8 billion |
Enteral Feeding Devices Market Size (2033) | USD 4.1 billion |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Short-term Growth: From 2017 to 2022, the global enteral feeding devices market registered a CAGR of 4.6%. The enteral feeding devices market held nearly 20.0% of the overall gastrointestinal device market, which is, valued at USD 12.5 billion in 2021.
Patients with low voluntary intake, persistent neurological or mechanical dysphagia, or gut malfunction, as well as those who are severely sick, benefit greatly from enteral feeding devices.
Many patients who formerly required parenteral nutrition can now be administered successfully with enteral nutrition alone or in conjunction with parenteral nutrition. The surging gastrointestinal access methods, better delivery systems, and breakthroughs in enteral feeding formulae are driving the demand for enteral feeding devices.
Mid-term Growth: The enteral feeding devices market is shifting away from hospital-based care towards home-based enteral nutrition (HEN). Because of escalating hospital expenditures, clinicians treating patients who require long-term nutritional care are increasingly turning to HEN.
Patients with certain chronic diseases are not required to be admitted to hospitals for enteral feeding treatments. Various solutions, such as portable feeding pumps and ready-to-use enteral feeding supplies, are commercially available. Medical service providers offer services related to enteral feeding at home.
Long-term Growth: Increasing adoption of enteral feeding in-home care settings and an increase in people suffering from chronic illnesses are two utmost drivers driving the enteral feeding devices market forward.
In addition, the advancements in healthcare diagnostic and treatment techniques have led to the provision of improved patient care by providing personalized solutions. Thereby, increasing the life expectancy for patients suffering from several chronic and other serious conditions. However, the market flourishes at a comparatively lower CAGR of 4.0% between 2023 and 2033.
In the coming years, the Asia Pacific region is likely to provide substantial development possibilities for market competitors. This is related to the region's diverse healthcare markets, the rising incidence of infectious and chronic diseases, and growing research and development activities to produce breakthrough medical technology.
Furthermore, infrastructure advances in healthcare facilities, rising healthcare spending, and growing low-cost manufacturing advantage in the region are projected to encourage market players to invest in the area in the coming years.
Gastrostomy buttons are low-profile gastrostomy devices that are growing in favor among G-tube users. Gastrostomy devices are especially well suited for children and active adults since the buttons are flush with the skin rather than protruding as a tube away from the body.
Despite the growing popularity of enteral feeding devices, currently, acceptable techniques include utilizing a surgical G-tube or PEG device to introduce a patient's initial G-tube.
The patient's tube can be replaced with a button device once the stoma has recovered. These advances are resulting in increased consumer satisfaction, which is creating an array of opportunities for the enteral feeding devices market ahead.
Companies interested in capitalizing on this growing market segment should start by developing a low-profile product for patient usage. Several companies, like Boston Scientific and Halyard Health, have already made the switch to one-step insertion kits for their button devices.
Physicians and key industry leaders indicated that an overall lack of patient education is negatively influencing the enteral feeding devices market. Many patients prefer to forego and effectively rule out enteral feeding as an option in some cases. Patients also lack an understanding of the benefits of prophylactic EN.
Lack of consumer awareness for procedures using enteral feeding devices limits the market space. Companies are trying to initiate legit campaigns to promote the use of enteral feeding devices.
Reimbursement can be a limiting factor affecting patients’ enteral feeding market growth. In developed nations such as the United States, Canada, Germany, France, the United Kingdom, and Japan, enteral nutrition treatment is covered by insurance. In underdeveloped nations spanning Asia Pacific, Latin America, and the Middle East, however, reimbursements for enteral feeding are minimal.
This provides a substantial hurdle to the broad adoption of enteral feeding. Furthermore, reduced government funding, high cost, and related reimbursement cuts for home healthcare services are likely to add to the issues encountered by enteral feeding device manufacturers in the forecast period.
Regions | Absolute Market Growth |
---|---|
United States | USD 364.8 million |
United Kingdom | USD 57.0 million |
China | USD 187.7 million |
Japan | USD 148.5 million |
South Korea | USD 50.1 million |
Strong Healthcare Systems along with Higher Investments for Enteral Feeding Systems post-pandemic is Propelling the Market Growth
Region | Attributes |
---|---|
United States Market CAGR (2023 to 2033) | 4.1% |
United States Market Absolute Doller Growth (USD million/billion) | USD 364.8 million |
As per FMI, sales in the United States enteral feeding devices market are expected to lead the market at a 4.1% CAGR over the forecast period, reaching a valuation of USD 1.1 billion in 2033.
The key driving factors behind the growth of the enteral feeding devices market include a rise in the incidence of chronic ailments, high acceptance of enteral feeding devices in home care settings, the availability of numerous well-equipped hospitals, as well as the steady transition from parenteral to enteral nutrition devices.
According to the latest data provided by the American Cancer Society, there were about 26,380 new cases of stomach cancer in the United States in 2022. (15,900 in men and 10,480 in women) This kind of cancer resulted in the deaths of around 11,090 people (6,690 men and 4,400 women). Since patients with stomach cancer require enteral nutrition, data show that demand for enteral feeding systems is expected to rise soon
Emerging Economies like China and India increase their Critical Care Spending to Restructure the Healthcare Systems
Region | Attributes |
---|---|
Chinese Market CAGR (2023 to 2033) | 4.9% |
Chinese Market Absolute Doller Growth (USD million/billion) | USD 187.7 million |
In 2021, China held a share of 46.8% in the East Asia enteral feeding devices market and is projected to expand at a CAGR of 4.9% from 2023 to 2033.
The growing awareness of the usage of enteral feeding devices, effective reimbursement policies, and a rise in the necessity for reconstructive surgery and radiation procedures are just a few of the causes driving up regional demand. The market is expected to cross a value of USD 495.3 million by 2033.
Moreover, key players in this market are focusing on launching theologically advanced products, which is contributing to the growth of enteral feeding device production and its usage.
Advanced Pumping Technology with Efficient and Easy Home-based Systems is gaining Traction in the Regional Market
Region | Attributes |
---|---|
Japanese Market CAGR (2023 to 2033) | 4.4% |
Japanese Market Absolute Doller Growth (USD million/billion) | USD 148.5 million |
The Japanese market is anticipated to have a significant share in the market over the forecast period, with sales growing at an average of 4.4% CAGR between 2023 and 2033. Total demand in the market is forecast to reach a valuation of USD 422.4 million by 2033, offering an absolute dollar opportunity of USD 148.5 million over the forecast period.
With Japan being the epicenter of technological implementations, it also contributes its share in the healthcare sector. Japanese physicians have researched the effects of enteral feeding solutions for pediatric Crohn's disease. The results came positive and hence it is recommended for the same in the region. This is likely to fuel the sales of enteral feeding devices in the region.
India held an 81.3% share in the South Asia enteral feeding devices market in 2021 and is projected to increase at a significant CAGR rate during the forecast period because of increased affordability, increased healthcare spending, and increased awareness of safe enteral feeding goods.
In addition, the count of premature babies is increasing across the country. Premature births and their consequences are the most common cause of infant death.
According to the most recent data from Newborn & Child Health and the World Health Organization, India ranks first among the ten countries that contribute 60% of the world's premature births, with 3,519,100 preterm births, or over 24% of the total number.
Prematurely born babies endure long-term health issues such as cerebral palsy, poor growth, and starvation. These negative events, together with an increase in chronic diseases, are expected to increase the use of enteral feeding devices in the country.
Germany is set to exhibit a significant CAGR in the European enteral feeding devices market during the forecast period. The increasing number of patients suffering from cancer, the growing geriatric population, the rising prevalence of neurological diseases, and increasing surgical procedures are likely to boost demand for enteral feeding devices to meet their nutritional needs.
Additionally, early approval of enteral feeding devices and the high adoption of enteral feeding pumps in this region is boosting the market growth.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Segment | Top Product Type |
---|---|
Top Sub-segment | Enteral Feeding Pumps |
CAGR (2017 to 2022) | 4.8% |
CAGR (2023 to 2033) | 5.2% |
Segment | Top End User |
---|---|
Top Sub-segment | Hospital |
CAGR (2017 to 2022) | 3.9% |
CAGR (2023 to 2033) | 3.4% |
Enteral feeding pumps are used as an alternative to gravity and syringe methods of feeding to deliver enteral nutrition across pediatric and adult populations diagnosed with chronic diseases to enhance nutritional intake and prevent malnutrition, adoption of enteral feeding pumps is significant in this population base which presents significant growth opportunities.
Furthermore, an increase in the usage of the feeding pumps and lesser side effects as compared to other devices makes this segment thrive at a CAGR of 5.2% between 2023 and 2033 in the global enteral feeding devices market.
Hospitals lead the enteral feeding devices market with a CAGR of 3.4% during the forecast period. The high availability of enteral feeding systems in hospitals contributes to the high utilization rate of these devices.
Furthermore, hospitals' strong financial capabilities for acquiring high-priced enteral feeding equipment such as enteral pumps, the huge patient pool treated at hospitals, and the accessibility of trained professionals to operate enteral feeding devices all contribute to the segment’s growth.
Leading players in the enteral feeding devices market are focusing on geographical expansion to gain high revenue & expand their sales footprint in emerging countries through different strategies.
Capacity expansion and adoption of new technology-based products are the key strategies adopted by manufacturers to increase the sale in different geographies
Additionally, manufacturers are focusing on forwarding integration with partnerships with wholesalers, distributors, and other channel partners to gain ownership over the value chain.
Recent Market Developments
Mixers and Mix-in Blenders
China, Japan, and India are the key Asian countries in the enteral feeding devices market.
The current market valuation of the enteral feeding devices market is estimated to be USD 2.8 billion in 2023.
The increasing use of minimally invasive procedures to insert enteral feeding tubes and the development of new materials for enteral feeding tubes that are more comfortable and less likely to cause complications.
Abbott Nutrition, ALCOR Scientific, Applied Medical Technology, B. Braun Melsungen AG, Boston Scientific, CONMED Corporation, Cook Medical, Cardinal Health, Inc., and Becton.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Enteral Feeding Pumps 5.2. PEGJ Tubes 5.3. Low-profile Tubes 5.3.1. Low-profile Balloon Tubes 5.3.2. Low-profile Non-Balloon Tubes 5.4. PEG Kit 5.4.1. PEG Balloon Kit 5.4.2. PEG Non-Balloon Kit 5.5. Replacement G-Tubes 5.5.1. Replacement Balloon G-Tubes 5.5.2. Replacement Non-Balloon G-Tubes 5.6. Nasojejunal Tubes 5.7. Nasogastric Tubes 6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Age Group 6.1. Adult 6.2. Pediatric 7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User 7.1. Hospital 7.2. Clinic 7.3. Ambulatory Surgical Center 7.4. Home Care Setting 8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region 8.1. North America 8.2. Latin America 8.3. Europe 8.4. East Asia 8.5. South Asia 8.6. Oceania 8.7. Middle East and Africa 9. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 10. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 11. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 12. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 13. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 14. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 15. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 16. Key Countries Market Analysis 17. Market Structure Analysis 18. Competition Analysis 18.1. Abbott Nutrition 18.2. ALCOR Scientific 18.3. Applied Medical Technology 18.4. B. Braun Melsungen AG 18.5. Boston Scientific 18.6. CONMED Corporation 18.7. Cook Medical 18.8. Cardinal Health, Inc. 18.9. Becton, Dickinson and Company 18.10. Fresenius Kabi 18.11. Owens & Minor, Inc. 18.12. Medline 18.13. Moog 18.14. Nestlé Health Science 18.15. Danone SA 18.16. Vygon SA 18.17. Amsino International, Inc. 18.18. Fuji Systems Corp 18.19. Neomed 18.20. Smiths Medical 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports